Quinagolide (HCl)
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Quinagolide (HCl) is an non-ergot dopamine receptor antagonist, the actions and uses are similar to those of bromocriptine. Quinagolide (HCl) is used in the treatment of such disorders associated with hyperprolactinemia.
Indications
Quinagolide (HCl) is primarily indicated in conditions like Adjuvant therapy in acromegaly, Hyperprolactinemia.
Contraindications
Quinagolide (HCl) is contraindicated in conditions like Depression, Impaired hepatic function, Psychiatric disease, Impaired renal function, Pregnancy, Mental illness.
Side Effects
The severe or irreversible adverse effects of Quinagolide (HCl), which give rise to further complications include Hypomania, Sexual disinhibition, Psychiatric disease. The signs and symptoms that are produced after the acute overdosage of Quinagolide (HCl) include Bradycardia, Hypotension, Nausea, Vomiting, Drowsiness, Collapse, Dizziness, Headache, Anxiety. The symptomatic adverse reactions produced by Quinagolide (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Nausea, Vomiting, Anorexia, Diarrhea, Constipation, Insomnia, Abdominal pain, Weight Loss, Hypotension, Flushing, Nasal congestion.
Warnings
It should be used cautiously in patients with history of heart attack, angina , liver or kidney disease, psychiatric illness or circulation problems in the fingers in cold weather. This medication should be used only when clearly needed during pregnancy. This drug is not recommended during lactation.
High Risk Groups
Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
75 to 150 mcg/day (110 (112.5)) As recommended. PO — Single patients may require daily doses of 300 micrograms or higher. In such cases, the daily dosage may be increased in steps of 75 micrograms to 150 micrograms at intervals not shorter than 4 weeks until satisfactory therapeutic effectiveness is achieved or reduced tolerability limits further increases in the dose.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Quinagolide (HCl) was found.
Storage
Tab Store at room temperature. Protect from Sunlight and Moisture.
Available Brands in Pakistan
No brands are recorded for this generic.